Mechanism underlying catecholaminergic polymorphic ventricular tachycardia and approaches to therapy

Journal of Electrocardiology

Volumn 44, Issue 6, 2011, Pages 650-655

  Watanabe, Hiroshi ^a   Knollmann, Björn C ^b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrhythmias; Calsequestrin; Genetics; Mechanism; Ryanodine channel

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ION; CALSEQUESTRIN; CASQ2 PROTEIN; FLECAINIDE; RYANODINE RECEPTOR 2; UNCLASSIFIED DRUG; VERAPAMIL;

ADRENERGIC SYSTEM; ARTICLE; AUTONOMIC DENERVATION; CALCIUM TRANSPORT; CARDIAC PATIENT; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; DEFIBRILLATOR; DRUG EFFICACY; EXERCISE TEST; GENE MUTATION; HEART DEPOLARIZATION; HEART PROTECTION; HEART STRESS; HEART VENTRICLE TACHYCARDIA; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR BLOCKING; REPRODUCIBILITY; SARCOPLASMIC RETICULUM; SUDDEN DEATH;

CALCIUM CHANNEL BLOCKERS; CALSEQUESTRIN; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; MUTATION; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TACHYCARDIA, VENTRICULAR;

EID: 80054943333     PISSN: 00220736     EISSN: 15328430     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2011.07.025     Document Type: Article

References (45)

1. A. Leenhardt, V. Lucet, I. Denjoy, F. Grau, D.D. Ngoc, and P. Coumel Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients Circulation 91 1995 1512
2. M. Hayashi, I. Denjoy, and F. Extramiana Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia Circulation 119 2009 2426
3. P.J. Laitinen, K.M. Brown, and K. Piippo Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia Circulation 103 2001 485
4. M. Cerrone, C. Napolitano, and S.G. Priori Catecholaminergic polymorphic ventricular tachycardia: A paradigm to understand mechanisms of arrhythmias associated to impaired Ca(2+) regulation Heart Rhythm 6 2009 1652
5. H. Lahat, E. Pras, and T. Olender A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel Am J Hum Genet 69 2001 1378
6. Z.A. Bhuiyan, M.A. Hamdan, and E.T. Shamsi A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22 J Cardiovasc Electrophysiol 18 2007 1060
7. D.J. Tester, P. Arya, and M. Will Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing Heart Rhythm 3 2006 800
8. S.G. Priori, C. Napolitano, and M. Memmi Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia Circulation 106 2002 69
9. S.G. Priori, C. Napolitano, and N. Tiso Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia Circulation 103 2001 196
10. L.M. Blayney, and F.A. Lai Ryanodine receptor-mediated arrhythmias and sudden cardiac death Pharmacol Ther 123 2009 151
11. M. Cerrone, B. Colombi, and M. Santoro Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor Circ Res 96 2005 e77
12. N. Liu, B. Colombi, and M. Memmi Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model Circ Res 99 2006 292
13. P.J. Kannankeril, B.M. Mitchell, and S.A. Goonasekera Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy Proc Natl Acad Sci USA 103 2006 12179
14. S.E. Lehnart, M. Mongillo, and A. Bellinger Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice J Clin Invest 118 2008 2230
15. D. Jiang, B. Xiao, L. Zhang, and S.R. Chen Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death Circ Res 91 2002 218
16. D. Jiang, B. Xiao, and D. Yang RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR) Proc Natl Acad Sci USA 101 2004 13062
17. D. Jiang, R. Wang, and B. Xiao Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death Circ Res 97 2005 1173
18. M. Fernandez-Velasco, A. Rueda, and N. Rizzi Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia Circ Res 104 2009 201 [212p following 209]
19. T. Kashimura, S.J. Briston, and A.W. Trafford In the RyR2(R4496C) mouse model of CPVT, beta-adrenergic stimulation induces Ca waves by increasing SR Ca content and not by decreasing the threshold for Ca waves Circ Res 107 2010 1483
20. X.H. Wehrens, S.E. Lehnart, and F. Huang FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death Cell 113 2003 829
21. X.H. Wehrens, S.E. Lehnart, and S.R. Reiken Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2 Science 304 2004 292
22. N. Ikemoto, and T. Yamamoto Regulation of calcium release by interdomain interaction within ryanodine receptors Front Biosci 7 2002 d671
23. H. Uchinoumi, M. Yano, and T. Suetomi Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor Circ Res 106 2010 1413
24. X. Xu, M. Yano, and H. Uchinoumi Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction Biochem Biophys Res Commun 394 2010 660
25. M. Cerrone, S.F. Noujaim, and E.G. Tolkacheva Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia Circ Res 101 2007 1039
26. G. Kang, S.F. Giovannone, and N. Liu Purkinje cells from RyR2 mutant mice are highly arrhythmogenic but responsive to targeted therapy Circ Res 107 2010 512
27. B.C. Knollmann New roles of calsequestrin and triadin in cardiac muscle J Physiol 587 2009 3081
28. B.C. Knollmann, N. Chopra, and T. Hlaing Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia J Clin Invest 116 2006 2510
29. L. Song, R. Alcalai, and M. Arad Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia J Clin Invest 117 2007 1814
30. N. Chopra, P.J. Kannankeril, and T. Yang Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice Circ Res 101 2007 617
31. M.R. di Barletta, S. Viatchenko-Karpinski, and A. Nori Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia Circulation 114 2006 1012
32. G. Valle, D. Galla, and A. Nori Catecholaminergic polymorphic ventricular tachycardia-related mutations R33Q and L167H alter calcium sensitivity of human cardiac calsequestrin Biochem J 413 2008 291
33. T.D. Houle, M.L. Ram, and S.E. Cala Calsequestrin mutant D307H exhibits depressed binding to its protein targets and a depressed response to calcium Cardiovasc Res 64 2004 227
34. D. Terentyev, A. Nori, and M. Santoro Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death Circ Res 98 2006 1151
35. E. Kim, B. Youn, and L. Kemper Characterization of human cardiac calsequestrin and its deleterious mutants J Mol Biol 373 2007 1047
36. N.C. Bal, A. Sharon, and S.C. Gupta The catecholaminergic polymorphic ventricular tachycardia mutation R33Q disrupts the N-terminal structural motif that regulates reversible calsequestrin polymerization J Biol Chem 285 2010 17188
37. N.C. Bal, N. Jena, and D. Sopariwala Probing cationic selectivity of Cardiac Calsequestrin and its CPVT mutants Biochem J 2011
38. A.E. Epstein, J.P. DiMarco, and K.A. Ellenbogen ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 2008 e350
39. U. Mohamed, M.H. Gollob, R.M. Gow, and A.D. Krahn Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia Heart Rhythm 3 2006 1486
40. S. Pizzale, M.H. Gollob, R. Gow, and D.H. Birnie Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation J Cardiovasc Electrophysiol 2008
41. R. Rosso, J.M. Kalman, and O. Rogowski Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia Heart Rhythm 4 2007 1149 [Epub 2007 May 1124]
42. H. Swan, P. Laitinen, K. Kontula, and L. Toivonen Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations J Cardiovasc Electrophysiol 16 2005 162
43. G. Katz, A. Khoury, and E. Kurtzwald Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice Heart Rhythm 7 2010 1676
44. H. Watanabe, N. Chopra, and D. Laver Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans Nat Med 15 2009 380
45. A.A. Wilde, Z.A. Bhuiyan, and L. Crotti Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia N Engl J Med 358 2008 2024